Reuters logo
10 个月前
BRIEF-Cerulean announces $20 mln firm commitment at-the-market stock purchase agreement with Aspire Capital Fund
2016年10月19日 / 中午12点23分 / 10 个月前

BRIEF-Cerulean announces $20 mln firm commitment at-the-market stock purchase agreement with Aspire Capital Fund

Oct 19 (Reuters) - Cerulean Pharma Inc

* Cerulean announces $20 million firm commitment at-the-market stock purchase agreement with Aspire Capital Fund

* Cerulean Pharma immediately following execution of purchase agreement, aspire purchased 800,000 shares of common stock for $1.25 per share

* Cerulean Pharma in connection with entering into purchase agreement, Cerulean issued 700,000 commitment shares to Aspire

* Cerulean has right to sell up to remaining $19.0 million of its common stock to aspire over a 24-month period Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below